GGrantIndex
← Leaderboards

Mary Kathryn Grabowski

Johns Hopkins University

$4,617,395
Attributed
$4,617,395
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,617,395 · 4

By mechanism

R01$3,735,853 · 2
K01$638,307 · 1
R21$243,235 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Surveys

Research focus

SurveysFutureAcquired Immunodeficiency SyndromeAfricanCommunitiesUgandaCohort StudiesIncidenceEmergency SituationEpidemiologyPhylogenetic AnalysisInterviewInfectionPrevalenceParticipantTransmission ProcessAids PreventionPopulation BasedAntiretroviral TherapyAfricaEpidemicCohortLinkHiv Risk

Grant awards (13)

Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP study$596,751
R01 · FY2025 · AI · contact PI
Direct from sample whole genome sequencing of Neisseria Gonorrhoeae to reveal patterns of STI epidemic synergy in African populations with high HIV burden$207,759
R21 · FY2025 · AI · contact PI
Direct from sample whole genome sequencing of Neisseria Gonorrhoeae to reveal patterns of STI epidemic synergy in African populations with high HIV burden$35,476
R21 · FY2025 · AI · contact PI
Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP study$661,316
R01 · FY2024 · AI · contact PI
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW Study$578,396
R01 · FY2024 · AI · contact PI
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW Study$608,890
R01 · FY2023 · AI · contact PI
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW Study$619,977
R01 · FY2022 · AI · contact PI
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW Study$670,523
R01 · FY2021 · AI · contact PI
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approach$127,678
K01 · FY2020 · AI · contact PI
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approach$127,614
K01 · FY2019 · AI · contact PI
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approach$127,586
K01 · FY2018 · AI · contact PI
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approach$127,868
K01 · FY2017 · AI · contact PI
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approach$127,561
K01 · FY2016 · AI · contact PI